Page last updated: 2024-08-24

aripiprazole and flb 457

aripiprazole has been researched along with flb 457 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CM; Frankle, WG; Himes, M; Keating, P; Laruelle, M; Mason, NS; Mathis, CA; May, MA; Narendran, R; Rabiner, EA1
Arakawa, R; Fujiwara, H; Ito, H; Kato, M; Kimura, Y; Kodaka, F; Mimura, M; Nagashima, T; Nogami, T; Sasaki, T; Shimada, H; Suhara, T; Suzuki, M; Takahata, K; Takano, H1

Trials

2 trial(s) available for aripiprazole and flb 457

ArticleYear
Evaluation of dopamine D₂/₃ specific binding in the cerebellum for the positron emission tomography radiotracer [¹¹C]FLB 457: implications for measuring cortical dopamine release.
    Synapse (New York, N.Y.), 2011, Volume: 65, Issue:10

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Carbon Radioisotopes; Cerebellum; Cerebral Cortex; Dopamine; Female; Humans; Male; Piperazines; Positron-Emission Tomography; Pyrrolidines; Quinolones; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Young Adult

2011
Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.
    Psychopharmacology, 2012, Volume: 222, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain; Carbon Radioisotopes; Corpus Striatum; Humans; Male; Piperazines; Positron-Emission Tomography; Pyrrolidines; Quinolones; Raclopride; Radiopharmaceuticals; Receptors, Dopamine D2; Salicylamides; Young Adult

2012